- Coagulant demand is mostly a contest with dissolved organic carbon. When your source-water TOC rises, the dose required to charge-neutralize and remove it rises with it — and so does sludge, oxidant demand, and filter loading.
- The same organic carbon is the precursor pool for disinfection byproducts. Coagulant cost and DBP compliance are two readouts of one underlying variable, which is why treating them separately is inefficient.
- That carbon is produced and concentrated in the reservoir — by algal growth and by internal nutrient cycling. Reducing the load at source attacks both problems at once, and the economics often favor the reservoir over the chemical-feed building.
The dose keeps creeping up
The coagulant line on your chemical budget has been drifting in the wrong direction. The jar tests call for more alum or ferric than they did a few years ago, the dose climbs every summer, sludge handling is heavier, filter runs are shorter, and the plant is quietly absorbing all of it as the cost of doing business. The instinct is to treat it as a plant-optimization question — better jar testing, a polymer aid, a flash-mix tweak. Those help at the margin. They do not address why the demand is rising, because the reason is not in the plant.
Coagulant demand is a fight with organic carbon
Coagulation removes turbidity, but in most surface-water plants the dose is set by something you cannot see: dissolved organic carbon. Natural organic matter in source water carries a negative charge. To remove it you have to neutralize that charge and sweep it into floc, and the metal coagulant is consumed in direct proportion to how much organic carbon is present. This is why "enhanced coagulation" is fundamentally about TOC removal rather than turbidity — the organics, not the particles, set the dose.
Two measurements describe the pool you are fighting. TOC quantifies how much organic carbon is present. UV254 — ultraviolet absorbance at 254 nm — tracks the aromatic, humic fraction that is both the most coagulant-hungry and the most reactive. The ratio of the two, specific UV absorbance, tells you what kind of organic matter you have and how amenable it is to removal by coagulation at all. A rising dose with rising UV254 is a different problem from a rising dose at flat UV254, and conflating them is how plants end up overdosing against the wrong fraction.
The character of the carbon matters as much as the quantity. Allochthonous organic matter washed in from the watershed is largely humic, high-SUVA, and removes reasonably well in coagulation. Autochthonous organic matter produced inside the reservoir by algae — algal-derived organic matter — is lower in SUVA, more hydrophilic, and removes poorly, which means an algae-driven TOC pulse can demand a disproportionate dose for the carbon it represents and still leave residual organics in the settled water. The reservoir does not just deliver carbon. It delivers carbon of a particular and often inconvenient character.
The same carbon becomes your DBP problem
Here is the coupling that makes this more than a chemical-cost story. The organic carbon you are dosing coagulant to remove is the precursor pool for disinfection byproducts. When the organics that survive coagulation meet chlorine downstream, they form trihalomethanes and haloacetic acids — the regulated DBPs you report against. Coagulant demand and DBP formation potential are not two problems. They are two readouts of one variable: the amount and character of organic carbon your reservoir sends to the plant.
That coupling is why source-water organics control has a reach that no plant adjustment can match. Lower the TOC entering the plant and the coagulant dose falls, the sludge volume falls, the oxidant demand falls, and the DBP precursor load falls — all from one intervention, because all of them trace back to one quantity. A plant chasing DBP compliance by re-sequencing disinfection while paying ever-higher coagulant doses is solving the same problem twice, downstream, at full price each time.
Why the reservoir is the cost lever
If the dose is set by algal-derived organic carbon, then the question is what produces that biomass — and the answer leads back to the nutrient supply, particularly phosphorus. A meaningful fraction of the summer phosphorus that drives algal growth in many reservoirs is internal: during stratification the hypolimnion goes anoxic, Fe(III) oxyhydroxides binding sediment phosphate are reduced to soluble Fe²⁺, and bioavailable PO₄³⁻ releases into the water column to feed the next bloom. The TOC pulse that raises your coagulant dose in August is the downstream signature of a phosphorus-release process happening in the sediment weeks earlier.
This is where the diagnosis lives, and it is a reservoir diagnosis, not a jar-testing exercise. The questions worth answering are: how much of the organic load is autochthonous versus allochthonous, and how does that split move across the season; how much of the algal growth is driven by internal phosphorus loading versus watershed inputs; and what the redox-mobile fraction of sediment phosphorus is, because that fraction sets the ceiling on how large the internal contribution can get. We characterize the organic load, model the nutrient supply that builds it, and quantify the sediment phosphorus pool that feeds the cycle. The output tells you whether your coagulant trend is a watershed problem, a sediment problem, or both — and therefore where a dollar spent actually reduces the dose.
The economics that justify looking upstream
A coagulant budget is a recurring annual cost, and so is the sludge disposal, the shortened filter capacity, and the oxidant spend that rides along with a high-organic source. Every one of those lines scales with the TOC the reservoir delivers. A source-water intervention that lowers that load — by reducing the algal production that generates the most troublesome organic fraction — is a one-time engineering cost against a permanent reduction in a recurring bill, and it improves DBP compliance margin in the same move. The reactive path pays full price for the same problem every year and never changes the input.
The case for looking upstream is not ideological. It is that the variable driving your coagulant demand, your sludge, and your DBP precursors is a single quantity set in the reservoir, and it is cheaper to reduce a load at its source than to remove it at full dose forever. If your plant is dosing its way through an organics problem that starts in the reservoir, that is a conversation worth having.
Stop buying coagulant by the truckload. Start managing the carbon at its source.